EYP001a
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for EYP001a, covering 2017-04-13 to 2023-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]